Free Trial

Centessa Pharmaceuticals (CNTA) Institutional Ownership

Centessa Pharmaceuticals logo
$39.85 -0.05 (-0.13%)
Closing price 04:00 PM Eastern
Extended Trading
$39.84 -0.02 (-0.04%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Centessa Pharmaceuticals (NASDAQ:CNTA)

Current
Institutional Ownership
Percentage
82.01%
Number of
Institutional Buyers
(last 12 months)
96
Total
Institutional Inflows
(last 12 months)
$1.08B
Number of
Institutional Sellers
(last 12 months)
54
Total
Institutional Outflows
(last 12 months)
$650.41M
Get CNTA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Centessa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CNTA Institutional Buying and Selling by Quarter

Centessa Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/29/2026 Perceptive Advisors LLC5,258,903$208.88M4.1%+80.2%3.524%
5/19/2026 Bank of America Corp DE1,932,406$76.76M0.0%+103.5%1.295%
5/19/2026 Janus Henderson Group PLC3,492,977$138.74M0.1%-14.7%2.341%
5/18/2026 Royal Bank of Canada1,164$46K0.0%-79.1%0.001%
5/18/2026 Rock Springs Capital Management LP351,828$13.98M0.8%+8.6%0.236%
5/18/2026 Eagle Health Investments LP214,291$8.51M1.5%+107.8%0.144%
5/16/2026 Torno Capital LLC20,000$794K0.1%N/A0.013%
5/16/2026 The Manufacturers Life Insurance Company 13,965$555K0.0%-93.4%0.009%
5/16/2026 Maverick Capital Ltd.1,854,488$73.66M0.8%+12.8%1.243%
5/16/2026 First Light Asset Management LLC1,560,991$62.00M5.6%-31.5%1.046%
5/16/2026 SummitTX Capital L.P.206,847$8.22M0.3%-37.8%0.139%
5/15/2026 Rangeley Capital LLC9,000$357K0.3%N/A0.006%
5/15/2026 Weiss Asset Management LP510,407$20.27M0.3%N/A0.342%
5/15/2026 Affinity Asset Advisors LLC1,400,000$55.61M2.9%+133.1%0.938%
5/15/2026 Spruce Street Capital LP489,849$19.46M4.7%+528.0%0.328%
5/14/2026 Renaissance Technologies LLC185,000$7.35M0.0%-33.8%0.124%
5/14/2026 Gabelli Funds LLC17,600$699K0.0%N/A0.012%
5/14/2026 GABELLI & Co INVESTMENT ADVISERS INC.9,400$373K0.1%N/A0.006%
5/14/2026 Siren L.L.C.1,053,464$41.84M1.2%-73.8%0.706%
5/14/2026 Knott David M Jr39,000$1.55M0.9%+875.0%0.026%
5/1/2026 Candriam S.C.A.36,254$1.44M0.0%-90.8%0.024%
4/27/2026 Private Advisor Group LLC6,000$238K0.0%N/A0.004%
4/27/2026 Y Intercept Hong Kong Ltd96,367$3.83M0.1%+742.3%0.065%
4/22/2026 Pictet Asset Management Holding SA96,910$3.85M0.0%N/A0.063%
4/16/2026 SG Americas Securities LLC3,081$122K0.0%-98.8%0.002%
3/3/2026 Caitong International Asset Management Co. Ltd3,218$80K0.0%N/A0.002%
2/19/2026 T. Rowe Price Investment Management Inc.1,536$39K0.0%+7,580.0%0.001%
2/18/2026 Coastal Bridge Advisors LLC14,033$351K0.0%+7.1%0.010%
2/18/2026 XTX Topco Ltd79,077$1.98M0.1%N/A0.059%
2/18/2026 Voloridge Investment Management LLC348,279$8.71M0.0%N/A0.259%
2/18/2026 Virtus Investment Advisers LLC10,034$251K0.1%+6.2%0.007%
2/18/2026 Wellington Management Group LLP50,180$1.26M0.0%-39.3%0.037%
2/18/2026 SummitTX Capital L.P.332,708$8.32M0.3%N/A0.248%
2/18/2026 Tudor Investment Corp ET AL121,810$3.05M0.0%+110.7%0.091%
2/18/2026 RTW Investments LP1,790,837$44.79M0.4%-21.9%1.332%
2/18/2026 Oxford Asset Management LLP11,166$279K0.1%N/A0.008%
2/18/2026 Perceptive Advisors LLC2,917,634$72.97M1.3%-5.9%2.171%
2/18/2026 Millennium Management LLC1,870,671$46.79M0.0%+119.5%1.392%
2/18/2026 Janus Henderson Group PLC4,093,608$102.39M0.0%-24.3%3.045%
2/18/2026 EcoR1 Capital LLC3,115,000$77.91M3.5%+466.4%2.317%
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
2/18/2026 Cinctive Capital Management LP72,831$1.82M0.1%-21.4%0.054%
2/18/2026 Commodore Capital LP1,000,000$25.01M1.7%-64.9%0.744%
2/18/2026 Cormorant Asset Management LP1,325,000$33.14M1.5%-31.2%0.986%
2/18/2026 Balyasny Asset Management L.P.468,815$11.73M0.0%-41.8%0.349%
2/18/2026 Baker BROS. Advisors LP670,751$16.78M0.1%N/A0.499%
2/18/2026 Boothbay Fund Management LLC32,508$813K0.0%-76.0%0.024%
2/18/2026 Armistice Capital LLC500,000$12.51M0.1%+32.3%0.372%
2/18/2026 5AM Venture Management LLC580,945$14.53M4.6%-14.7%0.432%
2/17/2026 Logos Global Management LP200,000$5.00M0.3%-61.9%0.149%
2/17/2026 ADAR1 Capital Management LLC38,566$965K0.1%-28.1%0.029%
2/17/2026 Burkehill Global Management LP150,000$3.75M0.2%N/A0.112%
2/17/2026 Braidwell LP2,188,320$54.73M1.8%N/A1.628%
2/17/2026 Jain Global LLC915,803$22.90M0.1%+278.5%0.681%
2/17/2026 First Light Asset Management LLC2,278,940$57.00M4.4%-37.3%1.695%
2/17/2026 Trexquant Investment LP146,523$3.67M0.0%+135.2%0.109%
2/17/2026 Farallon Capital Management LLC5,377,068$134.48M0.6%+24.1%4.000%
2/17/2026 Price T Rowe Associates Inc. MD3,927,343$98.22M0.0%-18.2%2.922%
2/17/2026 T. Rowe Price Investment Management Inc.1,536$39K0.0%+7,580.0%0.001%
2/17/2026 Rock Springs Capital Management LP324,015$8.10M0.4%+368.0%0.241%
2/17/2026 Adage Capital Partners GP L.L.C.11,281,741$282.16M0.4%+12.4%8.393%
2/17/2026 General Atlantic L.P.6,117,715$153.00M5.3%-36.8%4.551%
2/17/2026 Russell Investments Group Ltd.74,819$1.87M0.0%-59.0%0.056%
2/17/2026 Atom Investors LP18,347$459K0.0%N/A0.014%
2/17/2026 Fred Alger Management LLC162,147$4.06M0.0%-14.8%0.121%
2/17/2026 Avoro Capital Advisors LLC14,555,555$364.03M3.5%+34.7%9.966%
2/17/2026 Foresite Capital Management VI LLC1,364,019$34.11M10.3%+3.8%1.015%
2/16/2026 Squarepoint Ops LLC81,812$2.05M0.0%+321.4%0.061%
2/16/2026 Sofinnova Investments Inc.1,104,274$27.62M1.1%N/A0.822%
2/16/2026 Spruce Street Capital LP77,997$1.95M0.6%N/A0.058%
2/16/2026 Verition Fund Management LLC94,912$2.37M0.0%-17.0%0.071%
2/16/2026 Barclays PLC1,108$28K0.0%-77.7%0.001%
2/16/2026 Aigen Investment Management LP12,569$314K0.1%N/A0.009%
2/13/2026 Nantahala Capital Management LLC254,803$6.37M0.2%-37.1%0.190%
2/13/2026 Maverick Capital Ltd.1,643,724$41.11M0.4%N/A1.223%
2/13/2026 Marshall Wace LLP216,130$5.41M0.0%+90.3%0.161%
2/13/2026 The Manufacturers Life Insurance Company 211,253$5.23M0.0%-19.4%0.157%
2/13/2026 Walleye Capital LLC441,160$11.03M0.0%N/A0.328%
2/13/2026 Affinity Asset Advisors LLC600,552$15.02M0.9%-45.8%0.447%
2/13/2026 Siren L.L.C.4,027,517$100.73M3.0%+24.8%2.996%
2/13/2026 Caitong International Asset Management Co. Ltd1,436$36K0.1%N/A0.001%
2/13/2026 Wells Fargo & Company MN3,387$85K0.0%+42.4%0.003%
2/13/2026 Platinum Investment Management Ltd.155,101$3.88M0.9%-16.8%0.115%
2/13/2026 Rhenman & Partners Asset Management AB100,000$2.50M0.2%N/A0.074%
2/12/2026 HRT Financial LP11,020$275K0.0%N/A0.008%
2/12/2026 Renaissance Technologies LLC279,300$6.99M0.0%+69.7%0.208%
2/12/2026 Federated Hermes Inc.2,342,139$58.58M0.1%+33.9%1.742%
2/12/2026 Campbell & CO Investment Adviser LLC16,243$406K0.0%-37.2%0.012%
2/12/2026 Knott David M Jr4,000$100K0.0%N/A0.003%
2/11/2026 Deutsche Bank AG156,205$3.91M0.0%N/A0.116%
2/11/2026 Franklin Resources Inc.2,368,381$59.23M0.0%-7.4%1.762%
Elon Musk’s $1 Quadrillion AI IPO (Ad)

$1 quadrillion would be enough to send a $2.8 million check to every man, woman, and child in America. That is the scale of what analysts are calling the biggest AI IPO in history.And right now, you can claim a stake before the company goes public, starting with just $500.Elon Musk is predicting this investment could climb 1,000x from here. Early access is available today.tc pixel

2/11/2026 Capital World Investors1,158,699$28.98M0.0%+69.2%0.862%
2/10/2026 TD Asset Management Inc376,344$9.41M0.0%-19.4%0.280%
2/10/2026 Goldman Sachs Group Inc.779,001$19.48M0.0%+214.7%0.580%
2/10/2026 Seven Grand Managers LLC50,000$1.25M0.1%N/A0.037%
2/9/2026 Geode Capital Management LLC87,610$2.19M0.0%-7.8%0.065%
2/9/2026 Royce & Associates LP362,873$9.08M0.1%+46.7%0.270%
2/9/2026 Blue Owl Capital Holdings LP139,450$3.49M0.3%-17.7%0.104%
2/6/2026 PSP Research LLC21,879$547K0.5%N/A0.016%
2/6/2026 GSA Capital Partners LLP33,104$828K0.1%+76.5%0.025%
2/5/2026 DNB Asset Management AS12,746$319K0.0%+41.8%0.009%


CNTA Institutional Ownership - Frequently Asked Questions

During the previous two years, 154 institutional investors and hedge funds held shares of Centessa Pharmaceuticals. The most heavily invested institutionals were Avoro Capital Advisors LLC ($364.03M), Adage Capital Partners GP L.L.C. ($282.16M), Perceptive Advisors LLC ($208.88M), General Atlantic L.P. ($153.00M), Janus Henderson Group PLC ($138.74M), Farallon Capital Management LLC ($134.48M), and Price T Rowe Associates Inc. MD ($98.22M).Learn more on Centessa Pharmaceuticals' institutional investors.

82.01% of Centessa Pharmaceuticals' stock is owned by institutional investors. Learn more on CNTA's institutional investor holdings.

Of the 135 institutional investors that purchased Centessa Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Avoro Capital Advisors LLC ($9.56M), Adage Capital Partners GP L.L.C. ($5.45M), Janus Henderson Group PLC ($4.91M), Farallon Capital Management LLC ($3.36M), Perceptive Advisors LLC ($3.19M), EcoR1 Capital LLC ($2.57M), and Federated Hermes Inc. ($2.34M).

Institutional investors have bought a total of 43,375,506 shares in the last 24 months. This purchase volume represents approximately $1.08B in transactions.

Of the 54 institutional investors that sold Centessa Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: General Atlantic L.P. ($3.56M), First Light Asset Management LLC ($3.31M), Siren L.L.C. ($2.97M), Commodore Capital LP ($2.30M), Perceptive Advisors LLC ($2.08M), Janus Henderson Group PLC ($1.92M), and Affinity Asset Advisors LLC ($1.15M).

Institutional investors have sold a total of 24,662,320 shares in the last 24 months. This volume of shares sold represents approximately $650.41M in transactions.



This page (NASDAQ:CNTA) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners